Bacterial Meningitis in Older Children
Antibiotic choice, pediatric doses, organism-specific duration, and practical management points based on the Nelson approach.
Nelson-based • School-aged children & adolescents01. Initial approach
In an older child with suspected acute bacterial meningitis, treatment must begin urgently after blood cultures and lumbar puncture, if these can be obtained without delaying antibiotics.
Initial empirical treatment should cover the most likely pathogens, particularly Streptococcus pneumoniae and Neisseria meningitidis.
Regimen selection depends on age, immunization status, local antimicrobial resistance, allergy history, and whether the infection is community-acquired or healthcare-associated.
02. Empirical antibiotic therapy
For children older than 3 months, including school-aged children and adolescents, the classic empiric regimen is:
Administer intravenously at meningitis doses while awaiting CSF Gram stain, culture, and susceptibility results.
Pediatric meningitis doses
Ceftriaxone
Usually once daily, or 50 mg/kg/dose every 12 hours.
Cefotaxime
Divide into doses every 6 hours in the cited Nelson regimen.
Vancomycin
Divide into doses every 6 hours in the cited Nelson regimen. Monitor according to institutional protocol.
03. Antibiotic duration by organism
The following durations represent classic durations for uncomplicated bacterial meningitis. Modify treatment according to culture, susceptibility, clinical response, CSF sterilization, and complications.
| Organism | Preferred treatment and total duration |
|---|---|
| Streptococcus pneumoniae |
Ceftriaxone or cefotaxime if susceptible.
10–14 days.
If resistant to penicillin and third-generation cephalosporins, continue an active regimen guided by susceptibility, including vancomycin when indicated. |
| Neisseria meningitidis | Penicillin G if susceptible, or ceftriaxone/cefotaxime. 5–7 days. |
| Haemophilus influenzae | Ceftriaxone or cefotaxime, particularly for beta-lactamase-producing strains. 7–10 days. |
| Unknown bacterial pathogen | Ceftriaxone or cefotaxime. 7–10 days may be appropriate in an uncomplicated, clinically improving child when the CSF profile supports bacterial meningitis but no organism is identified. |
| Gram-negative bacilli | Use an active agent such as cefotaxime, ceftazidime, or another susceptibility-directed antibiotic. Treatment is generally prolonged, often at least 3 weeks in the classic regimen. |
Other clinically important pathogens
| Pathogen | Treatment and duration |
|---|---|
| Listeria monocytogenes | Ampicillin; usually at least 21 days in high-risk patients. |
| Group B Streptococcus | Usually 14–21 days. |
| Pseudomonas aeruginosa | An active antipseudomonal agent, such as ceftazidime or cefepime, selected according to susceptibility. Prolonged treatment is often required. |
04. Culture-directed treatment
Once the CSF Gram stain, culture, PCR, and susceptibility results become available, narrow therapy to the most appropriate active antibiotic.
Suspected bacterial meningitis
Start ceftriaxone or cefotaxime plus vancomycin IV.Identify the pathogen
Review CSF Gram stain, culture, PCR, and antimicrobial susceptibility results.Narrow the antibiotic regimen
Stop vancomycin when it is no longer needed and the identified organism is adequately covered by the selected beta-lactam, provided susceptibility and clinical circumstances support de-escalation.Complete the appropriate course
Continue organism-specific treatment, accounting for effective therapy, prior antibiotics, clinical response, complications, and CSF sterilization.When should vancomycin be continued?
Continue vancomycin when there is a meaningful possibility of cephalosporin-resistant pneumococcal meningitis, until susceptibility results permit narrowing.
If the pneumococcus is susceptible to ceftriaxone or cefotaxime, a third-generation cephalosporin can generally be used alone.
05. Practical bedside points
06. Exam-oriented recall
A 9-year-old child presents with acute bacterial meningitis. Before culture results are available, what is the most appropriate empiric regimen?
This combination provides empiric coverage of common bacterial meningitis pathogens, including potentially resistant Streptococcus pneumoniae. Once culture and susceptibility results are available, therapy should be narrowed appropriately.
07. Rapid revision
| Question | High-yield answer |
|---|---|
| Empiric therapy in older children? | Ceftriaxone or cefotaxime + vancomycin. |
| Typical pneumococcal duration? | 10–14 days. |
| Typical meningococcal duration? | 5–7 days. |
| Typical Hib duration? | 7–10 days. |
| When can vancomycin be stopped? | When susceptibility and clinical circumstances support narrowing. |
| Should LP delay antibiotics? | No. |
08. References and clinical note
Primary reference: Nelson Textbook of Pediatrics — bacterial meningitis: initial antibiotic therapy and duration of treatment.
Additional clinical guidance: Canadian Paediatric Society — Management of bacterial meningitis
Important: Confirm the current edition-specific Nelson recommendations, maximum doses, local antimicrobial resistance patterns, and institutional pediatric antimicrobial protocol before applying treatment to a patient.
